← Back to Search

Other

Battlefield Acupuncture for Hidradenitis Suppurativa

N/A
Recruiting
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Significant pain from hidradenitis at least twice weekly
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up average score from scores recorded daily for 4 weeks
Awards & highlights

Study Summary

This trial will test whether acupuncture can help relieve the pain of hidradenitis suppurativa, a condition that causes red, painful lumps under the skin.

Who is the study for?
This trial is for adults over 18 with a dermatologist-confirmed diagnosis of hidradenitis suppurativa, experiencing significant pain from the condition at least twice weekly. Participants must be on a stable treatment regimen for hidradenitis during the study and have no other chronic pain or ear issues that would interfere with acupuncture.Check my eligibility
What is being tested?
The trial is testing battlefield acupuncture against sham (fake) acupuncture to see if it can reduce pain in patients with hidradenitis suppurativa. Battlefield acupuncture involves placing tiny needles in specific points on the ear.See study design
What are the potential side effects?
Potential side effects may include minor bleeding, bruising, or soreness at needle insertion sites on the ear. There's also a small risk of infection and discomfort during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience significant pain from hidradenitis at least twice a week.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with hidradenitis suppurativa by a dermatologist.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~average score from scores recorded daily for 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and average score from scores recorded daily for 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Pain Numerical Rating Score

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TreatmentExperimental Treatment1 Intervention
2 treatments of battlefield acupuncture to the bilateral ears spaced one week apart
Group II: ControlPlacebo Group1 Intervention
2 treatments with sham acupuncture to the bilateral ears at acupuncture points not associated with pain relief (2 liver and 1 stomach)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Battlefield Acupuncture
2016
Completed Phase 2
~410

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor
309 Previous Clinical Trials
109,243 Total Patients Enrolled
1 Trials studying Hidradenitis Suppurativa
30 Patients Enrolled for Hidradenitis Suppurativa

Media Library

Battlefield Acupuncture (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04218422 — N/A
Hidradenitis Suppurativa Research Study Groups: Control, Treatment
Hidradenitis Suppurativa Clinical Trial 2023: Battlefield Acupuncture Highlights & Side Effects. Trial Name: NCT04218422 — N/A
Battlefield Acupuncture (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04218422 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total enrollment quota for this clinical trial?

"Correct. The clinical trial is currently inviting volunteers for participation and the information posted on clinicaltrials.gov confirms this. This medical study was initially published on January 22nd 2020, with a recent update made on May 3rd 2022; it requires 32 patients to be enrolled at one site in total."

Answered by AI

Are there any vacant slots left for volunteers in this clinical exploration?

"Data available on clinicaltrials.gov attests to this medical experiment's search for participants, which began on January 22nd 2020 and was recently updated May 3rd 2022."

Answered by AI
~19 spots leftby Dec 2030